Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zahra Sabourinejad"'
Autor:
Majid Momeny, Ghazaleh Zarrinrad, Farima Moghaddaskho, Arash Poursheikhani, Ghazaleh Sankanian, Azam Zaghal, Shahab Mirshahvaladi, Fatemeh Esmaeili, Haniyeh Eyvani, Farinaz Barghi, Zahra Sabourinejad, Zivar Alishahi, Hassan Yousefi, Reza Ghasemi, Leila Dardaei, Davood Bashash, Bahram Chahardouli, Ahmad R. Dehpour, Javad Tavakkoly-Bazzaz, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed H. Ghaffari
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy worldwide. Development of chemoresistance and peritoneal dissemination of EOC cells are the major reasons for low survival rate. Targeting signal transduction pathw
Externí odkaz:
https://doaj.org/article/371260993ffc4717abe454c0586b4782
Autor:
Kamran Alimoghaddam, Fatemeh Esmaeili, Zivar Alishahi, Seyed H. Ghaffari, Narjes Shahsavani, Majid Momeny, Sepehr Javadikooshesh, Javad Tavakkoly-Bazzaz, Davood Bashash, Ghazaleh Zarrinrad, Ghazaleh Sankanian, Ardeshir Ghavamzadeh, Zahra Sabourinejad, Arash Poursheikhani, Sahar Shamsaiegahkani, Hassan Yousefi, Nazanin Parsanejad
Publikováno v:
Tumori Journal. 105:84-91
Introduction: Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy worldwide and despite an initial response to therapeutic agents, the majority of patients have chemoresistant disease. There is no treatment strategy with proven
Autor:
Farinaz Barghi, Fatemeh Esmaeili, Seyed H. Ghaffari, Somaye Vaezijoze, Ardeshir Ghavamzadeh, Ghazaleh Zarrinrad, Davood Bashash, Seyyed Mohammad Tavangar, Ahmad Reza Dehpour, Zahra Sabourinejad, Elaheh S. Aboutorabi, Ghazaleh Sankanian, Kamran Alimoghaddam, Hassan Yousefi, Majid Momeny, Parisa Ghaffari, Haniyeh Eyvani, Sepideh Hamzehlou, Sahar Shamsaiegahkani, Javad Tavakkoly-Bazzaz, Zivar Alishahi, Ali Salehi, Farima Moghaddaskho
Publikováno v:
International Journal of Biochemistry and Cell Biology. 99:1-9
Epithelial ovarian cancer (EOC) has exhibited marginal improvement in survival rate, despite advances in surgical debulking and chemotherapy regimens. Although the majority of EOC patients achieve a clinical remission after induction therapy, over 80
Autor:
Javad Tavakkoly-Bazzaz, Fatemeh Esmaeili, Ahmad Reza Dehpour, Zahra Sabourinejad, Seyed H. Ghaffari, Reza Ghasemi, Bahram Chahardouli, Azam Zaghal, Hassan Yousefi, Davood Bashash, Haniyeh Eyvani, Farinaz Barghi, Farima Moghaddaskho, Ardeshir Ghavamzadeh, Leila Dardaei, Majid Momeny, Arash Poursheikhani, Ghazaleh Sankanian, Ghazaleh Zarrinrad, Shahab Mirshahvaladi, Zivar Alishahi, Kamran Alimoghaddam
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy worldwide. Development of chemoresistance and peritoneal dissemination of EOC cells are the major reasons for low survival rate. Targeting signal transduction pathways which
Autor:
Ardeshir Ghavamzadeh, Farinaz Barghi, Ghazaleh Zarrinrad, Shahab Mirshahvaladi, Ensieh M. Poursani, Davood Bashash, Kamran Alimoghaddam, Seyed H. Ghaffari, Farima Moghaddaskho, Arash Poursheikhani, Majid Momeny, Mahmoud Ghazi-Khansari, Hassan Yousefi, Seyyed Mohammad Tavangar, Haniyeh Eyvani, Marjan Yaghmaie, Leila Dardaei, Ahmad Reza Dehpour, Zahra Sabourinejad
Publikováno v:
Scientific Reports
Epithelial ovarian cancer (EOC) is the most fatal gynaecological malignancy. Despite initial therapeutic response, the majority of advanced-stage patients relapse and succumb to chemoresistant disease. Overcoming drug resistance is the key to success
Autor:
Ardeshir Ghavamzadeh, Farinaz Barghi, Kamran Alimoghaddam, Leila Dardaei, Saeid Amanpour, Leila Ahmadinia, Farima Moghaddaskho, Seyed H. Ghaffari, Ahmad Reza Dehpour, Zahra Sabourinejad, Seyyed Mohammad Tavangar, Ghazaleh Zarrinrad, Shahab Mirshahvaladi, Narges K Gortany, Majid Momeny, Mahmoud Ghazi-Khansari, Haniyeh Eyvani, Hassan Yousefi, Amir Hossein Emami
Publikováno v:
Scientific Reports
Glioblastoma (GBM) remains one of the most fatal human malignancies due to its high angiogenic and infiltrative capacities. Even with optimal therapy including surgery, radiotherapy and temozolomide, it is essentially incurable. GBM is among the most
Autor:
Zahra Sabourinejad, Farinaz Barghi, Zivar Alishahi, S.H. Ghaffari, F. Esmaeili, Hassan Yousefi, Ghazaleh Zarrinrad, Haniyeh Eyvani, Ghazaleh Sankanian, Javad Tavakkoly-Bazzaz, S. Vaezijoze, Sahar Shamsaiegahkani, Majid Momeny, E. Aboutorabi, Farima Moghaddaskho, Kamran Alimoghaddam, Arash Poursheikhani, A. Ghavamzadeh
Publikováno v:
Annals of Oncology. 28:x68-x69
Autor:
Farima Moghaddaskho, Arash Poursheikhani, M. Yaghmaiee, A. Ghavamzadeh, Haniyeh Eyvani, Hassan Yousefi, Ghazaleh Zarrinrad, Farinaz Barghi, S.H. Ghaffari, Zahra Sabourinejad, Kamran Alimoghaddam, F. Esmaeilii, Majid Momeny
Publikováno v:
Annals of Oncology. 27:ix97-ix98